Accessibility Menu
iAnthus Capital logo

iAnthus Capital(OTC) ITHUF

Current Price$0.00
Market Cap$16.68MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2016)-100%
5 Year-97%
1 Year-16%
1 Month-11%
iAnthus Capital last closing stock price
MetricPriceDate
Last closeUSD 0.002026-07-22
iAnthus Capital stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0.96%USD 0.002026-07-15
1 month-10.64%USD 0.002026-06-22
3 month-5.62%USD 0.002026-04-23
Year to date-20.75%USD 0.012025-12-31
1 year-16%USD 0.012025-07-22
3 year-74.04%USD 0.022023-07-21
5 year-97.47%USD 0.172021-07-23
Since inception-99.63%USD 1.152016-09-09

iAnthus Capital Financials at a Glance

Market Cap

$16.68MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$139.92M

Net Income (TTM)

-$59.68M

EPS (TTM)

-$0.01

P/E Ratio

-0.48

Dividend

$0.00

Beta (Volatility)

0.39 (Low)

Price

$0.00

Volume

2,721

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.01

Estimated Earnings Date

Aug 17, 2026

ITHUF News

cannabis greenhouse

3 Underrated Pot Stocks to Buy in 2020

David Jagielski, CPAFeb 22, 2020
Investor Looking at Financials Magnifying Glass Getty

Aurora Cannabis Takes a Huge Writedown, and These Pot Stocks May Follow Suit

Sean WilliamsFeb 12, 2020
cannabis green light

iAnthus Commences Operations in Its Tenth State: New Jersey

David Jagielski, CPAFeb 4, 2020
Marijuana USA Cannabis Flower Pot Weed Scale Joint Bag Legal Getty

6 U.S. Pot Stocks Operating in at Least 10 States

Sean WilliamsFeb 2, 2020
Magnifying Glass Marijuana Plant Cannabis Pot Weed Medical Recreational Leagal Grow Getty

3 Marijuana Stocks Trading Below Their Book Value

Sean WilliamsJan 23, 2020
Magnifying Glass Marijuana Plant Cannabis Pot Weed Medical Recreational Leagal Grow Getty

3 Cannabis Stocks at High Risk of a Writedown

Sean WilliamsJan 16, 2020
Marijuana USA Cannabis Flower Pot Weed Scale Joint Bag Legal Getty

The 5 Biggest Concerns for U.S. Pot Stocks

Sean WilliamsOct 23, 2019
Value Trap Mouse Trap Hand With Money Getty

Marijuana Value Traps Do Exist: Here Are 3 to Avoid

Sean WilliamsOct 5, 2019
Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About iAnthus Capital

iAnthus Capital Holdings, Inc. operates a network of licensed cannabis cultivation, processing, and retail dispensary facilities across the United States. The company offers a diverse range of cannabis products, including raw biomass, infused items, and CBD products, catering to both wholesale and retail markets.

Products and Services
  • Raw cannabis biomass, including pre-rolls and infused items
  • Concentrated products such as vape cartridges and oils
  • CBD products, including topical creams and beauty essentials
Growth Outlook
  • Operational footprint spans 8 states with 32 dispensaries
  • Continued expansion in the growing cannabis market
  • Focus on enhancing product offerings and distribution channels
Financial Highlights
  • Q1 2026 revenue of 33.5 million, showing strong market demand
  • Gross profit margin improved to 47.5% in Q1 2026
  • Net income for Q1 2026 was -14.1 million, reflecting ongoing investment
iAnthus Capital Holdings, Inc. is positioned in the rapidly expanding cannabis industry, managing a significant number of dispensaries and cultivation sites. The company's diverse product portfolio caters to a wide range of consumer preferences, from traditional cannabis products to innovative CBD offerings. The growth outlook remains positive, with a strategic focus on expanding operational capabilities and enhancing product distribution. Recent financial performance indicates a strong revenue stream, with Q1 2026 revenue reaching 33.5 million, underscoring the company's ability to capture market demand. The gross profit margin has also shown improvement, reflecting operational efficiencies and effective cost management. Despite reporting a net loss in Q1 2026, the ongoing investments in infrastructure and product development are expected to position iAnthus for future profitability as the cannabis market continues to mature. The company's commitment to expanding its footprint and product offerings may attract potential investors looking for opportunities in the evolving cannabis sector.
AI Generated • Jul 21, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

792

CEO

Richard Proud

Website

www.ianthus.com

Headquarters

Toronto, ON M5H 3S6, CA

ITHUF Financials

Key Financial Metrics (TTM)

Gross Margin

41.13%

Operating Margin

-10.57%

Net Income Margin

-42.65%

Return on Equity

61.62%

Return on Capital

-11.72%

Return on Assets

-23.33%

Earnings Yield

-2.08%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$16.68MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

3.97B

Volume

2.72K

Avg. Volume

175.22K

Financials (TTM)

Gross Profit

$57.55M

Operating Income

-$14.79M

EBITDA

$3.27M

Operating Cash Flow

$1.04M

Capital Expenditure

-$20.99M

Free Cash Flow

-$19.95M

Cash & ST Invst.

$11.14M

Total Debt

$232.95M

iAnthus Capital Performance Analysis

iAnthus Capital annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 163,213,000-19.6%
20232023-12-31USD 159,237,000-2.4%
20242024-12-31USD 167,567,0005.2%
20252025-12-31USD 143,986,000-14.1%
iAnthus Capital sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-7.7%
Q32025-09-300.6%
Q42025-12-311.3%
Q12026-03-31-6.5%
iAnthus Capital annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.07-84.4%
20232023-12-31USD -0.01-83.0%
20242024-12-31USD -0.00-89.9%
20252025-12-31USD -0.01400.0%
iAnthus Capital sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-450.0%
Q32025-09-3032.1%
Q42025-12-31-10.5%
Q12026-03-314.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$33.51M

-12.1%

Gross Profit

$15.92M

-15.7%

Gross Margin

47.51%

N/A

Market Cap

$16.68MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$23.30K

N/A

Employees

716

N/A

Net Income

-$14.11M

-374.0%

EBITDA

$2.35M

-87.8%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$11.14M

-54.1%

Total Debt

$232.95M

+9.7%

Accounts Receivable

$6.75M

-32.2%

Inventory

$24.55M

+27.1%

Long Term Debt

$225.88M

+16.6%

Short Term Debt

$14.11M

-24.4%

Return on Assets

-23.33%

N/A

Return on Invested Capital

-8.04%

N/A

Free Cash Flow

-$1.03M

+37.7%

Operating Cash Flow

$1.01M

-67.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CNTMFFluent Corp.
$0.03+8.57%
ELIXFElixxer Ltd.
$0.03+0.00%
WOWUWOWI, Inc.
$0.00+0.00%
MDDVFMedical Developments International Limited
$0.37+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.88-0.28%
TQQQProShares Trust - ProShares UltraPro Qqq
$65.73-0.06%
SMCISuper Micro Computer
$31.09+0.02%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$43.59+0.06%

Questions About ITHUF

What is the current price of iAnthus Capital?

iAnthus Capital is trading at $0.00 per share.

What is the 52-week range for iAnthus Capital?

Over the past 52 weeks, iAnthus Capital has traded between $0.00 and $0.01.

How much debt does iAnthus Capital have?

As of the most recent reporting period, iAnthus Capital reported total debt of $232.19M.

How much cash does iAnthus Capital have on hand?

iAnthus Capital reported $11.21M in cash and cash equivalents in its most recent financial results.

What is iAnthus Capital’s dividend yield?

iAnthus Capital does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services